TRPV4 study identifies a neural 'stop-scratching' mechanism in chronic itch

Scientists have identified a key molecular and neural mechanism behind the built-in braking system that tells the brain when to stop scratching an itch. In a mouse study to be presented at the 70th Biophysical Society Annual Meeting in San Francisco from February 21–25, 2026, researchers found that the ion channel TRPV4 helps trigger a negative feedback signal that tells the spinal cord and brain that scratching has been sufficient.

Researchers at the University of Louvain in Brussels revealed an unexpected role for TRPV4 in mechanically evoked itch. TRPV4 belongs to a family of ion channels that act as molecular gates in the membranes of sensory neurons, allowing ions to flow in response to physical or chemical stimuli. These channels help the nervous system detect temperature, pressure, and tissue stress, but TRPV4's role in itch, and especially in chronic itch, has remained controversial.

To address this question with precision, the team engineered a genetic mouse model, selectively deleting TRPV4 only in sensory neurons. This neuron-specific approach avoided a major limitation of earlier studies, in which TRPV4 was removed from all tissues, making it difficult to pinpoint where the channel was actually acting. Using a combination of genetic tools, calcium imaging, and behavioral assays, the researchers demonstrated that TRPV4 is expressed in neurons classically associated with touch, called Aβ low-threshold mechanoreceptors (Aβ-LTMRs), as well as in subsets of sensory neurons linked to itch and pain pathways, including those expressing TRPV1.

When the team induced a chronic itch condition resembling atopic dermatitis, mice lacking neuronal TRPV4 scratched less frequently, but each scratching bout lasted much longer than normal. The data suggest that TRPV4 does not simply generate itch. Instead, in mechanosensory neurons, it helps trigger a negative feedback signal, a neural message that tells the spinal cord and brain that scratching has been sufficient. Without this signal, the sensation of relief is blunted, and scratching continues excessively.

The findings suggest that TRPV4's role in itch is more complex than previously thought. While the channel in skin cells appears to trigger itch sensations, the same channel in neurons seems to help regulate and restrain them. The findings suggest that broadly blocking TRPV4 may not be the solution, and that future therapies may need to be much more targeted, perhaps acting only in the skin without interfering with the neuronal mechanisms that tell the body when to stop scratching.

Chronic itch affects millions of people with conditions like eczema, psoriasis, and kidney disease, yet effective treatments remain limited. Understanding the precise mechanisms that regulate itch, including when to stop scratching, could open new avenues for therapeutic development.